Will Drugmaker Cheplapharm Hold $ 10 Billion IPO?

Opinions

Ella Jones, Deputy Editor In Chief

Date: 09.03.2021

Cheplapharm Arzneimittel GmbH, the German drugmaker, is weighing plans for an initial public offering in what could be one of Europe’s largest share sales of 2021, people familiar with the matter said.

Greifswald-based Cheplapharm is speaking with advisers about a potential listing as soon as this year, the people said, asking not to be identified discussing confidential information. A share sale could value the business at about 7 billion euros to 8 billion euros ($ 9.5 billion) or more, the people said.

A representative for Cheplapharm declined to comment.

Cheplapharm offers treatments for heart conditions, cancer and infectious diseases. Its drugs are available in more than 120 countries, according to its website.

Cheplapharm joins a host of other German companies, including language app Babbel and dating platform ParshipMeet, in planning potential listings as high valuations draw more companies to market.

by Ella Jones | Linkedin

Views: 16

Leave a request

Select option
Thank you, application submitted.